Melphalan is a cancer medication. Melphalan interferes with the growth of cancer cells and slows their growth and spread in the body. Melphalan is used to treat multiple myeloma (a type of blood cancer), cancer of the ovary, and breast cancer. Melphalan may also be used for other purposes not listed in this medication guide.
Alkeran is a chemotherapeutic drug used in the treatment of conditions such as multiple myeloma, ovarian cancer, AL amyloidosis and retinoblastoma. The active pharmaceutical ingredient of the medicine is melphalan. Belonging to a class of drugs known as alkylating agents, Alkeran works by interfering in the DNA replication process of cancerous cells, thereby destroying them. Alkeran is typically administered by intravenous infusion over 20 minutes every couple of weeks, depending on the regimen chosen by the oncologist. Side-effects include immunosuppression, which may lead to an increased risk of infection and bleeding.